/PRNewswire/ AffaMed Technologies ("AffaMed"), a joint venture established between AffaMed Therapeutics and SIFI S.p.A., today announced the completion of.
. and commercializing innovative immuno - oncology therapies and precision medicines, today . It has also been granted Breakthrough Therapy Designation by .